Cell And Gene Therapy Manufacturing

  1. Interview With Pharma Analytics Field Application Specialist - Sandi True 11/6/2025

    Hear Sandi True, a Field Applications Specialist discuss helping customers navigate challenges often encountered when evaluating and implementing Residual DNA Quantitation, Mycoplasma Detection, and Microbial Identification Assays.

  2. CTS DynaCellect Magnetic Separation System Cell Isolation 5/22/2025

    Ready to achieve high-purity results in your cell therapy manufacturing? This step-by-step guide demonstrates the complete setup and installation for your automated magnetic cell isolation system and kit.

  3. HyPerforma 5:1 Single-Use Bioreactor (S.U.B.) Setup And Installation Part 2 5/7/2020

    This video is part 2 of 3 videos that cover setup and installation topics related to the HyPerforma 5:1 Single-Use Bioreactor, or S.U.B. In this video we will cover initial BioProcess Container, or BPC, loading, drive shaft insertion, final installation steps.

  4. Tackling Residual DNA Testing In Biotherapy Manufacturing 7/16/2025

    Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.

  5. Cytovance And Thermo Fisher Scientific Single-Use Equipment Collaboration 11/10/2025

    This video highlights the success Cytovance has had solving complex issues with our Thermo Scientific imPULSE Single-Use Mixers (S.U.M.s) HyPerforma Single-Use Fermentors (S.U.F.s) and BioProcess Containers (BPCs).

  6. Focal Points for 2024: Dr. Verdun and Dr. Marks Talk Regulatory Challenges for Cell-Based Therapies 1/30/2024

    Dr. Verdun and Dr. Marks provide detailed feedback on the regulatory challenges facing cell therapy and explain the Agency’s most important focal points for 2024, patient accessibility, and more.

  7. Developing A 2-Step Chromatographic Process For The Purification Of AAV Vectors 6/24/2025

    POROS CaptureSelect AAVX and POROS 50 HQ were tested for capture and polishing, respectively, of AAV2, AAV9 and a novel engineered capsid to achieve vectors with high purity and significant empty: full ratio improvement.

  8. Rethinking Sustainability In Bioprocessing 5/22/2025

    Discover how sustainability is transforming bioprocessing through innovative single-use technologies that help reduce environmental impact and support responsible, forward-thinking biomanufacturing.

  9. Enhancing AAV Purification In Gene Therapy Manufacturing 6/2/2025

    Review chromatography solutions for purifying multiple AAV serotypes, with specialists’ insights on bioprocessing and downstream optimization.

  10. Why Clinical Requirements Change: Dr. Peter Marks on Pre-IND Meeting Pathways 1/30/2024

    Learn how clinical requirements change after the FDA and a company agree on a pathway during a pre-IND meeting and how the company might recover as a result.